Search the Newsreel

PAII|Pyrophyte Acquisition Corp II|Price:10.235|Chg%:+0.005

This article provides a detailed financial overview of Pyrophyte Acquisition Corp II (PAII), a blank check company. It includes current stock price, market capitalization, key financial figures, technical indicator analysis, and major shareholders. The company has not yet disclosed EPS or total revenue data, …

PAII|Pyrophyte Acquisition Corp II|Price:10.240|Chg%:-0.010

This article provides a detailed financial overview of Pyrophyte Acquisition Corp II (PAII), a blank check company. It includes current stock price, market capitalization, key financial figures, technical indicator analysis, and major shareholders. The company has not yet disclosed EPS or total revenue data, …

Spyre Therapeutics Inc (SYRE) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis of Spyre Therapeutics Inc (SYRE), detailing its current valuation score, P/E ratio, and ranking within the Biotechnology & Medical Research industry. It notes that several key valuation metrics like P/B, P/S, and P/CF have not yet been disclosed …

ETFs Investing in Spyre Therapeutics, Inc Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Spyre Therapeutics, Inc. (SYRE). It provides a detailed table including each fund's market value, weight of SYRE in the fund, issuer, management style, focus, expense ratio, assets under management (AUM), price, change …

Spyre Therapeutics Inc. (SYRE) Q1 2026 Earnings: Pre-Revenue Biotech Reports Wider-than-Expected Loss, Stock Gains 6.5% - Earnings Revision Report

SYRE Stock Draws Analyst Upgrades As Volatility Spikes

Spyre Therapeutics Inc.'s stock (SYRE) is experiencing increased volatility and analyst upgrades following positive clinical trial data for its inflammatory bowel disease platform. Mizuho and Deutsche Bank have raised their price targets significantly, reflecting optimism about the company's lead drug SPY120 and its multi-asset …

Spyre Therapeutics stock hits 52-week high at 102.46 USD

Spyre Therapeutics (SYRE) stock reached a new 52-week high of $102.46, marking a significant surge from its 52-week low. This performance is attributed to positive phase 2 trial results for SPY002 targeting ulcerative colitis and completed enrollment for SPY072 in rheumatic diseases, alongside optimistic …

Empyrean Energy Director Steps Down After Two Decades of Service

AIM Market Roundup: Celsius Resources, Empyrean Energy, Sunda Energy

REG - Empyrean Energy PLC - Mako Gas Project Update

Pyramid: Prognose-Update in Kürze

Pyramid: Wenn die Prognose eintritt…

Pyramid Technoplast approves ₹500 cr borrowing limit

Pyramid Technoplast's (NSE:PYRAMID) Shareholders May Want To Dig Deeper Than Statutory Profit

Pyramid Techno Standalone March 2026 Net Sales at Rs 194.79 crore, up 13.76% Y-o-Y

Pyramid Technoplast standalone net profit rises 51.59% in the March 2026 quarter

Pyramid Technoplast Posts 51% Q4 Profit Surge to ₹100M with Strong 15% FY27 Growth Target

Pyramid Technoplast Files Q4FY26 Share Capital Audit Report with SEBI

Pyramid AG AKTIE | Aktienkurs & News | A41YDL – boerse.de

Pyramid AG verfehlt EBITDA-Ziel – Asien drückt Ergebnis

Empyrean Energy PLC (AIM: EME) Final Investment Decision Approved for Mako Gas Project

Empyrean Energy shares jump on cash-call sentiments

Empyrean Energy shares rocket as cash-call settlement deal is announced

Some Confidence Is Lacking In PyroGenesis Inc. (TSE:PYR) As Shares Slide 26%

Pyramid Technoplast Reports 25% Jump in Q2 EBITDA, Margin Improves and Announces Management Change

Gesamtverschuldung je Aktie von Pyrum Innovations AG – SWB:PYR

Pyramid Technoplast Shareholders Approve All Resolutions at 27th AGM, Including Asset Disposal Powers

Pyrum Innovations muss die Prognose für 2025 anpassen

Pyramid Technoplast Ltd Dividend History, Yield & Record Date

Pyramid AG übernimmt RNT und hebt Jahresziele an

Empyrean Energy tops up fund raise with retail offer

Pyramid Technoplast IPO: All you need to know

Pyramid AG Aktie | Kurs | Dividende | Nachrichten (A254W5, DE000A254W52)

Pyrum Innovations AG Aktie | Kurs | Dividende | Nachrichten (A2G8ZX, DE000A2G8ZX8)

PyroGenesis Canada Inc. (PYR) Stock Forecast & Price Prediction 2026–2030

Aktuelle Kennzahlen PYRUM INNOVATIONS Aktie